PARLIAMENTARY WRITTEN QUESTION
Parkinson's Disease: Newcastle-under-Lyme (30 August 2024)
Question Asked
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of procuring Produodopa via the NHS on the treatment of Parkinson's disease in Newcastle-Under Lyme constituency.
Asked by:
Adam Jogee (Labour)
Asked by:
Adam Jogee (Labour)
Answer
The National Institute for Health and Care Excellence (NICE) published guidance recommending foslevodopa–foscarbidopa (Produodopa) for patients with Parkinson’s disease meeting specified clinical criteria, in November 2023. Produodopa is now available to eligible National Health Service patients in England, including in Newcastle-Under Lyme, in line with the NICE’s recommendations.
Answered by:
Karin Smyth (Labour)
9 September 2024
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.